Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Cancer Research|May 4, 2005
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumorsKatia Scotlandi, Maria Cristina Manara, Giordano Nicoletti, et al.
Cells|March 12, 2020
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human OsteosarcomaDimas Carolina Belisario, Muhlis Akman, Martina Godel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2011
Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survivalKatia Scotlandi, Maria Cristina Manara, Massimo Serra, et al.
BMC Medical Genomics|January 23, 2014
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapyMarieke L Kuijjer, Brendy E W M van den Akker, Riet Hilhorst, et al.
Plos One|November 8, 2012
Modulation of the osteosarcoma expression phenotype by microRNAsHeidi M Namløs, Leonardo A Meza-Zepeda, Tale Barøy, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 25, 2025
Microfluidic-assisted synthesis of integrin-targeting cRGD liposomes as a scalable strategy for theranostic applications in triple-negative breast cancerKarina Ovejero-Paredes, Giovanni Bisbano, Inge Flier, et al.
Oncotarget|August 28, 2016
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcomaClaudia M Hattinger, Paola Biason, Erika Iacoboni, et al.
International Journal of Oncology|January 24, 2014
Molecular profiling of chordomaStefanie Scheil-Bertram, Roland Kappler, Alexandra von Baer, et al.
International Journal of Cancer|June 23, 2009
Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP)Diana Zambelli, Monia Zuntini, Filippo Nardi, et al.
Molecular Biology of the Cell|January 20, 2006
CD99 acts as an oncosuppressor in osteosarcomaMaria Cristina Manara, Ghislaine Bernard, Pier-Luigi Lollini, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Cancer Research|May 4, 2005
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumorsKatia Scotlandi, Maria Cristina Manara, Giordano Nicoletti, et al.
Cells|March 12, 2020
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human OsteosarcomaDimas Carolina Belisario, Muhlis Akman, Martina Godel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2011
Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survivalKatia Scotlandi, Maria Cristina Manara, Massimo Serra, et al.
BMC Medical Genomics|January 23, 2014
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapyMarieke L Kuijjer, Brendy E W M van den Akker, Riet Hilhorst, et al.
Plos One|November 8, 2012
Modulation of the osteosarcoma expression phenotype by microRNAsHeidi M Namløs, Leonardo A Meza-Zepeda, Tale Barøy, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 25, 2025
Microfluidic-assisted synthesis of integrin-targeting cRGD liposomes as a scalable strategy for theranostic applications in triple-negative breast cancerKarina Ovejero-Paredes, Giovanni Bisbano, Inge Flier, et al.
Oncotarget|August 28, 2016
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcomaClaudia M Hattinger, Paola Biason, Erika Iacoboni, et al.
International Journal of Oncology|January 24, 2014
Molecular profiling of chordomaStefanie Scheil-Bertram, Roland Kappler, Alexandra von Baer, et al.
International Journal of Cancer|June 23, 2009
Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP)Diana Zambelli, Monia Zuntini, Filippo Nardi, et al.
Molecular Biology of the Cell|January 20, 2006
CD99 acts as an oncosuppressor in osteosarcomaMaria Cristina Manara, Ghislaine Bernard, Pier-Luigi Lollini, et al.
Pageof 16